Meftagesic P 50mg/125mg Tablet DT
Marketer
Blue Cross Laboratories Ltd
Salt Composition
Mefenamic Acid (50mg) + Paracetamol (125mg)
Overview Meftagesic P 50mg/125mg Tablet DT
Each Meftagesic P 50mg/125mg Tablet DT combines two active components, both classified as non-steroidal anti-inflammatory drugs (NSAIDs). This medication effectively reduces fever, pain, and inflammation (swelling and redness) in infants and children. Administer this medication orally to your child precisely as prescribed, ideally at the same time each day. While it may be given with or without food, post-meal administration minimizes stomach upset. If your child vomits within 30 minutes, repeat the dose. Never exceed the recommended dosage; doing so could lead to adverse reactions. Minor side effects, such as nausea, vomiting, abdominal pain, heartburn, and diarrhea, may occur; these are usually temporary and self-limiting. However, persistent or troubling side effects necessitate immediate consultation with your child's physician. Prior to administering Meftagesic P 50mg/125mg Tablet DT, disclose any known allergies, pre-existing heart conditions, birth defects, liver, kidney, or lung disease, or bleeding disorders to your child's doctor. This information is essential for accurate dosage and treatment planning.
Uses of Meftagesic P 50mg/125mg Tablet DT
Analgesia and antipyresis
Major Benefits of Meftagesic P 50mg/125mg Tablet DT:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Dissolve the Meftagesic P 50mg/125mg Tablet DT in water before ingestion. Consumption may coincide with meals or be taken on an empty stomach; however, consistent timing is recommended.
Common Side effects of Meftagesic P 50mg/125mg Tablet DT:
- Nausea
- Vomiting
- Abdominal pain
- Heartburn
- Diarrhea
- Dizziness
How to use Meftagesic P 50mg/125mg Tablet DT:
Administer this medication according to your physician's prescribed dosage and schedule. Dissolve the tablet in water prior to ingestion. Meftagesic P 50mg/125mg Dispersible Tablets can be consumed with or without food; however, consistent timing is recommended.
How Meftagesic P 50mg/125mg Tablet DT works:
Mefenamic acid and paracetamol, both non-steroidal anti-inflammatory drugs (NSAIDs), are the active components of Meftagesic P 50mg/125mg DT tablets. This formulation functions by inhibiting the production of substances that trigger fever, pain, and inflammatory responses such as redness and swelling.
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Meftagesic P 50mg/125mg Delayed-Release tablets. Dosage modification of Meftagesic P 50mg/125mg Delayed-Release tablets may be necessary. Physician consultation is advised. Meftagesic P 50mg/125mg Delayed-Release tablets are not recommended for children with severe kidney disease.
LiverSAFE IF PRESCRIBED
Meftagesic P 50mg/125mg extended-release tablets are considered safe for use in individuals with hepatic impairment. Dosage modification of Meftagesic P 50mg/125mg extended-release tablets is unnecessary. However, routine liver function testing is advised for pediatric patients undergoing prolonged treatment with Meftagesic P 50mg/125mg extended-release tablets.
What if you forget to take Meftagesic P 50mg/125mg Tablet DT :
Remain calm. Administer the forgotten dose immediately upon recollection. Omit the missed dose, however, if the next dose is due or if your pediatrician advised against replacing missed doses. Avoid doubling the dose; adhere strictly to the recommended dosage regimen.
Facts to Know About Meftagesic P 50mg/125mg Tablet DT
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |






